Combination therapy of a novel oral fluorouracil derivative S-1 with low-dose cisplatin for unresectable and recurrent gastric cancer: JFMC27–9902 phase I trial

B. Nakata; A. Tsuji; Y. Mitachi; S. Yamamitsu; K. Hirata; T. Shirasaka; S. Saji; K. Inokuchi; K. Hirakawa

doi:10.1200/jco.2004.22.90140.4128

Combination therapy of a novel oral fluorouracil derivative S-1 with low-dose cisplatin for unresectable and recurrent gastric cancer: JFMC27–9902 phase I trial

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.4128 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 4128-4128

Author(s):

B. Nakata ◽

A. Tsuji ◽

Y. Mitachi ◽

S. Yamamitsu ◽

K. Hirata ◽

...

Keyword(s):

Gastric Cancer ◽

Combination Therapy ◽

Phase I ◽

Phase I Trial ◽

Low Dose ◽

Recurrent Gastric Cancer

Download Full-text

Combination therapy of a novel oral fluorouracil derivative S-1 with low-dose cisplatin for unresectable and recurrent gastric cancer: JFMC27–9902 phase I trial

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.4128 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 4128-4128

Author(s):

B. Nakata ◽

A. Tsuji ◽

Y. Mitachi ◽

S. Yamamitsu ◽

K. Hirata ◽

...

Keyword(s):

Gastric Cancer ◽

Combination Therapy ◽

Phase I ◽

Phase I Trial ◽

Low Dose ◽

Recurrent Gastric Cancer

Download Full-text

Combination Phase I Trial of a Novel Oral Fluorouracil Derivative S-1 with Low-Dose Cisplatin for Unresectable and Recurrent Gastric Cancer (JFMC27–9902)

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-03-0045 ◽

2004 ◽

Vol 10 (5) ◽

pp. 1664-1669 ◽

Cited By ~ 28

Author(s):

Bunzo Nakata ◽

Yasushi Mitachi ◽

Akihito Tsuji ◽

Susumu Yamamitsu ◽

Koichi Hirata ◽

...

Keyword(s):

Gastric Cancer ◽

Phase I ◽

Phase I Trial ◽

Low Dose ◽

Recurrent Gastric Cancer

Download Full-text

Phase I/II trial of combination therapy with S-1 and weekly paclitaxel in patients with unresectable or recurrent gastric cancer

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-008-0736-4 ◽

2008 ◽

Vol 63 (2) ◽

pp. 267-273 ◽

Cited By ~ 9

Author(s):

Seisuke Inada ◽

Takashi Tomidokoro ◽

Hiroyuki Fukunari ◽

Tomomi Sato ◽

Toru Hatano ◽

...

Keyword(s):

Gastric Cancer ◽

Combination Therapy ◽

Phase I ◽

Weekly Paclitaxel ◽

Recurrent Gastric Cancer

Download Full-text

Phase I/II Study of Combination Therapy of Oral Fluorinated Pyrimidine Compound S-1 with Low-dose Cisplatin in Patients with Unresectable and/or Recurrent Advanced Gastric Cancer: a Novel Study Design to Evaluate Safety and Efficacy

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyh031 ◽

2004 ◽

Vol 34 (3) ◽

pp. 159-161 ◽

Cited By ~ 1

Author(s):

S. Morita

Keyword(s):

Gastric Cancer ◽

Combination Therapy ◽

Phase I ◽

Advanced Gastric Cancer ◽

Study Design ◽

Low Dose ◽

Safety And Efficacy

Download Full-text

A Phase I Study of Combination Therapy of the Oral Fluorinated Pyrimidine Compound S-1 with Low-dose Cisplatin Twice-a-week Administration (JFMC27-9902 Step2) in Patients with Advanced Gastric Cancer Using a Continual Reassessment Method

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hym124 ◽

2007 ◽

Vol 37 (12) ◽

pp. 924-929 ◽

Cited By ~ 7

Author(s):

S. Morita ◽

B. Nakata ◽

A. Tsuji ◽

Y. Mitachi ◽

T. Shirasaka ◽

...

Keyword(s):

Gastric Cancer ◽

Combination Therapy ◽

Phase I ◽

Advanced Gastric Cancer ◽

Phase I Study ◽

Low Dose ◽

Continual Reassessment Method ◽

Continual Reassessment

Download Full-text

A phase I study of BBI608, a cancer stemness inhibitor, administered with paclitaxel (PTX) as combination therapy (Rx) for pretreated unresectable or recurrent gastric cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.e15089 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. e15089-e15089 ◽

Cited By ~ 2

Author(s):

Kohei Shitara ◽

Yasutoshi Kuboki ◽

Yoshiaki Nakamura ◽

Ayako Doi ◽

Kazuaki Harada ◽

...

Keyword(s):

Gastric Cancer ◽

Combination Therapy ◽

Phase I ◽

Phase I Study ◽

Cancer Stemness ◽

Recurrent Gastric Cancer

Download Full-text

Imatinib mesylate for targeting the platelet-derived growth factor β receptor in combination with fluorouracil and leucovorin in patients with refractory pancreatic, bile duct, colorectal, or gastric cancer—A dose-escalation Phase I trial

Cancer ◽

10.1002/cncr.22622 ◽

2007 ◽

Vol 109 (9) ◽

pp. 1897-1904 ◽

Cited By ~ 18

Author(s):

Salah-Eddin Al-Batran ◽

Akin Atmaca ◽

Eberhard Schleyer ◽

Claudia Pauligk ◽

Christian Hosius ◽

...

Keyword(s):

Gastric Cancer ◽

Growth Factor ◽

Bile Duct ◽

Phase I ◽

Imatinib Mesylate ◽

Dose Escalation ◽

Phase I Trial ◽

Platelet Derived Growth Factor ◽

Β Receptor

Download Full-text

Abstract CT214: ATRiUM: A first-in-human dose escalation phase I trial of ceralasertib (AZD6738) and gemcitabine as combination therapy

10.1158/1538-7445.am2021-ct214 ◽

2021 ◽

Author(s):

Bruno Henrique de Paula ◽

Bristi Basu ◽

Adrian Mander ◽

Josephine Khan ◽

Purity Bundi ◽

...

Keyword(s):

Combination Therapy ◽

Phase I ◽

Dose Escalation ◽

Phase I Trial ◽

Human Dose

Download Full-text

Phase I Trial of Sequential Low-Dose 5-Aza-2′-Deoxycytidine Plus High-Dose Intravenous Bolus Interleukin-2 in Patients with Melanoma or Renal Cell Carcinoma

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-06-0883 ◽

2006 ◽

Vol 12 (15) ◽

pp. 4619-4627 ◽

Cited By ~ 95

Author(s):

Jared A. Gollob ◽

Catherine J. Sciambi ◽

Bercedis L. Peterson ◽

Tina Richmond ◽

Monica Thoreson ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Phase I ◽

Cell Carcinoma ◽

Renal Cell ◽

Phase I Trial ◽

Low Dose ◽

Interleukin 2 ◽

High Dose ◽

Intravenous Bolus

Download Full-text

Updated results from a phase I trial of M7824 (MSB0011359C), a bifunctional fusion protein targeting PD-L1 and TGF-β, in patients with pretreated recurrent or refractory gastric cancer

Annals of Oncology ◽

10.1093/annonc/mdy282.045 ◽

2018 ◽

Vol 29 ◽

pp. viii222-viii223 ◽

Cited By ~ 5

Author(s):

Y.-J. Bang ◽

T. Doi ◽

S. Kondo ◽

H.C. Chung ◽

K. Muro ◽

...

Keyword(s):

Gastric Cancer ◽

Fusion Protein ◽

Phase I ◽

Phase I Trial ◽

Protein Targeting ◽

Bifunctional Fusion Protein

Download Full-text